DS
ARLZ

DRW Securities’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

DRW Securities’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,000
Closed -$26K – 115
2017
Q1 		$26K Sell
12,000
-18,766
-61% -$70.5K ﹤0.01% 72
2016
Q4 		$136K Sell
30,766
-54,699
-64% -$260K 0.01% 67
2016
Q3 		$415K Buy
+85,465
New +$390K 0.03% 52

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return

DRW Securities's ARLZ Position: Q2 2017 in Review

DRW Securities sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2017, closing a stake of 12,000 shares — an estimated $26K sold.

DRW Securities first reported a position in ARLZ in Q3 2016 and held it in 3 quarters. The position peaked at $415K in Q3 2016. 72 funds tracked by Wall St. Rank hold ARLZ as of Q2 2017.

  • DRW Securities reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2017 after selling out during the quarter.
  • DRW Securities sold 12,000 Aralez Pharmaceuticals Inc. shares in Q2 2017, an estimated $26K.
  • DRW Securities first reported a position in Aralez Pharmaceuticals Inc. in Q3 2016 and held it in 3 quarters.
  • DRW Securities's Aralez Pharmaceuticals Inc. position peaked at $415K in Q3 2016.
  • 72 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2017.

Based on DRW Securities's 13F filing for Q2 2017, filed 15 Aug 2017.